STOCK TITAN

Windward Bio CFO reports 927,760-share holding

Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
3

Rhea-AI Filing Summary

WINDWARD BIO GROUP AG (WWB) Chief Financial Officer Claudia D'Augusta reported direct ownership of 927,760 common shares and an employee share option covering 33,206 underlying common shares on November 12, 2026. The option has an exercise price of $0.02 per share and expires April 30, 2036. It vested or will vest in 36 equal monthly installments beginning April 30, 2026, subject to continuous service on each vesting date.

Insider D'Augusta Claudia
Role Chief Financial Officer
Type Security Shares Price Value
Holding Employee Share Option (Right to Buy) F2, F1 -- -- --
Holding Common Shares -- -- --
Holdings: Employee Share Option (Right to Buy) — 33,206 options (Direct); Common Shares — 927,760 shares (Direct)
Footnotes (2)
  1. F1. This option vested or will vest in 36 equal monthly installments on the last day of the relevant month commencing on April 30, 2026, subject to the Reporting Person's continuous service as of each such vesting date.
  2. F2. The exercise price is in US Dollars and reflects the conversion of CHF to USD at an exchange rate of $1.122 to CHF 1.00 as of November 6, 2026.
Direct common shares 927,760 shares Claudia D'Augusta's reported holding on November 12, 2026
Option underlying shares 33,206 common shares Employee share option reported on November 12, 2026
Exercise price $0.02 per share USD amount converted from CHF at $1.122 per CHF 1.00 as of November 6, 2026
Vesting installments 36 equal monthly installments Beginning April 30, 2026, subject to continuous service on each vesting date
Option expiration April 30, 2036 Expiration date of the employee share option
Currency conversion rate $1.122 per CHF 1.00 Rate as of November 6, 2026, used for the exercise price
Employee Share Option (Right to Buy) financial
"Employee Share Option (Right to Buy)"
vested or will vest financial
"vested or will vest in 36 equal monthly installments"
continuous service financial
"subject to the Reporting Person's continuous service"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many WWB shares does CFO Claudia D'Augusta directly hold?

Claudia D'Augusta, WINDWARD BIO GROUP AG's Chief Financial Officer, reported direct ownership of 927,760 common shares on November 12, 2026.

What option did WWB CFO Claudia D'Augusta report?

She reported an employee share option covering 33,206 underlying common shares, with an exercise price of $0.02 per share and an expiration date of April 30, 2036. It vested or will vest in 36 equal monthly installments starting April 30, 2026, subject to continuous service on each vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
D'Augusta Claudia

(Last)(First)(Middle)
C/O WINDWARD BIO GROUP AG
AESCHENPLATZ 6

(Street)
BASEL4052

(City)(State)(Zip)

SWITZERLAND

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
11/12/2026
3. Issuer Name and Ticker or Trading Symbol
WINDWARD BIO GROUP AG [ WWB ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares927,760D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Share Option (Right to Buy) (1)04/30/2036Common Shares33,206$0.02(2)D
Explanation of Responses:
1. This option vested or will vest in 36 equal monthly installments on the last day of the relevant month commencing on April 30, 2026, subject to the Reporting Person's continuous service as of each such vesting date.
2. The exercise price is in US Dollars and reflects the conversion of CHF to USD at an exchange rate of $1.122 to CHF 1.00 as of November 6, 2026.
/s/ Scott Applebaum, Attorney-in-Fact11/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Keep reading